The journal of nutrition health & aging,
Год журнала:
2023,
Номер
27(11), С. 1150 - 1150
Опубликована: Ноя. 1, 2023
n
fact,
you
are
right
in
several
of
the
comments
extracted
from
article
published
by
Belafsky
2008.However,
we
believe,
as
explained
our
article,
that
experience
and
results
with
EAT-10
provided
many
clinical
research
teams
all
around
world
during
last
15
years,
summarized
fully
supports
its
use
a
screening
tool
for
oropharyngeal
dysphagia
(OD).As
defined
original
study,
"the
is
self-administered
survey
instrument
subjective
assessment
dysphagia".You
et
al.
studied
validity
reliability
not
only
patients
dysphagia,
but
also
esophageal
head
neck
cancer
gastroesophageal
reflux
disease.As
proposed
Belafsky,
was
developed
to
«document
initial
severity
monitor
treatment
response
persons
wide
array
swallowing
disorders
(1).This
objective
aligns
paper's
scope,
sought
explore
specific
application
this
OD
achieve
goal,
analyzed
up
47
studies
described
table
1
manuscript.We
want
clarify
do
propose
diagnostic
substitute
or
replacement
current
gold
standard
diagnosis.As
stated
paper,
emphasize
«The
standardized
could
serve
primary
routine
practice
across
range
diseases
settings,
thereby
enhancing
likelihood
early
diagnosis
management"
(2).As
clearly
manuscript,
algorithm
(Figure
2)
requires
threestep
approach
consisting
instrumental
assessments.Patients
who
have
'failed'
test
at
risk
require
further
and/or
assessment(s).The
phase
aims
identify
OD,
signs
symptoms
mechanisms
pathophysiology
impaired
safety
efficacy
select
optimal
treatment.You
sentence
paper
should
be
"…EAT-10
provide
way
reporting
identifying
prevalence
OD".
While
the
surgical
treatment
of
mandibular
stage
3
medication-related
osteonecrosis
jaw
(MRONJ)
is
well-documented,
research
on
maxillary
MRONJ
limited.
Antiresorptive
medications
can
induce
and
atypical
femoral
fracture
(AFF),
but
their
impact
feasibility
using
fibula
flaps
for
reconstruction
remains
controversial.
This
study
aimed
to
assess
outcomes
functional
recovery
flap
MRONJ,
considering
both
recipient
donor
site
outcomes.
retrospective
included
patients
with
who
underwent
reconstruction.
Demographic
clinical
features,
postoperative
complications,
long-term
sites
were
analyzed.
Long-term
survival
flaps,
incidence
graft
or
tibia
fractures,
recurrence
patient
status.
Function
assessments
focused
speech,
swallowing,
ankle
joint.
Seven
(two
multiple
myeloma,
five
bone
metastases)
included.
Two
experienced
delayed
healing
at
site,
whom
recovered
within
two
months
postoperatively.
All
survived
primary
healing.
There
no
recurrences
fractures
tibia.
The
mean
speech
function
score
was
28.00
±
12.03,
swallowing
2.86
2.79,
pain
2.71
2.29,
94.43
4.35.
Fibula
feasible
yielding
satisfactory
recovery.
The journal of nutrition health & aging,
Год журнала:
2023,
Номер
27(11), С. 1150 - 1150
Опубликована: Ноя. 1, 2023
n
fact,
you
are
right
in
several
of
the
comments
extracted
from
article
published
by
Belafsky
2008.However,
we
believe,
as
explained
our
article,
that
experience
and
results
with
EAT-10
provided
many
clinical
research
teams
all
around
world
during
last
15
years,
summarized
fully
supports
its
use
a
screening
tool
for
oropharyngeal
dysphagia
(OD).As
defined
original
study,
"the
is
self-administered
survey
instrument
subjective
assessment
dysphagia".You
et
al.
studied
validity
reliability
not
only
patients
dysphagia,
but
also
esophageal
head
neck
cancer
gastroesophageal
reflux
disease.As
proposed
Belafsky,
was
developed
to
«document
initial
severity
monitor
treatment
response
persons
wide
array
swallowing
disorders
(1).This
objective
aligns
paper's
scope,
sought
explore
specific
application
this
OD
achieve
goal,
analyzed
up
47
studies
described
table
1
manuscript.We
want
clarify
do
propose
diagnostic
substitute
or
replacement
current
gold
standard
diagnosis.As
stated
paper,
emphasize
«The
standardized
could
serve
primary
routine
practice
across
range
diseases
settings,
thereby
enhancing
likelihood
early
diagnosis
management"
(2).As
clearly
manuscript,
algorithm
(Figure
2)
requires
threestep
approach
consisting
instrumental
assessments.Patients
who
have
'failed'
test
at
risk
require
further
and/or
assessment(s).The
phase
aims
identify
OD,
signs
symptoms
mechanisms
pathophysiology
impaired
safety
efficacy
select
optimal
treatment.You
sentence
paper
should
be
"…EAT-10
provide
way
reporting
identifying
prevalence
OD".